These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8676203)

  • 1. Radioiododeoxyuridine in cancer therapy: an in vitro approach to developing in vivo strategies.
    Schneiderman MH; Schneiderman GS
    J Nucl Med; 1996 Apr; 37(4 Suppl):6S-9S. PubMed ID: 8676203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor uptake and mitotic activity pattern of 5-[125I]iodo-2'- deoxyuridine after intravesical infusion in patients with bladder cancer.
    Mariani G; Collecchi P; Baldassarri S; Di Luca L; Buralli S; Fontanini G; Baranowska-Kortylewicz J; Adelstein SJ; Kassis AI
    J Nucl Med; 1996 Apr; 37(4 Suppl):16S-19S. PubMed ID: 8676197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiolabeled nucleoside analogs in cancer diagnosis and therapy.
    Kassis AI; Adelstein SJ; Mariani G
    Q J Nucl Med; 1996 Sep; 40(3):301-19. PubMed ID: 8961807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential cytotoxicity of [123I]IUdR, [125I]IUdR and [131I]IUdR to human glioma cells in monolayer or spheroid culture: effect of proliferative heterogeneity and radiation cross-fire.
    Neshasteh-Riz A; Mairs RJ; Angerson WJ; Stanton PD; Reeves JR; Rampling R; Owens J; Wheldon TE
    Br J Cancer; 1998; 77(3):385-90. PubMed ID: 9472632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical animal studies with radioiododeoxyuridine.
    Kassis AI; Adelstein SJ
    J Nucl Med; 1996 Apr; 37(4 Suppl):10S-12S. PubMed ID: 8676195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iododeoxyuridine uptake in proliferating smooth muscle cells in vitro.
    Xu Y; Jagtap MR; Garland T; Ying J; McGarry RC; Mendonca MS; McLennan G
    J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):73-8. PubMed ID: 17296707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular suicide studies of 125I and 3H disintegration in the DNA of Chinese hamster cells.
    Burki HJ; Koch C; Wolff S
    Curr Top Radiat Res Q; 1978 Jan; 12(1-4):408-25. PubMed ID: 565272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radionuclide toxicity in cultured mammalian cells: elucidation of the primary site of radiation damage.
    Warters RL; Hofer KG; Harris CR; Smith JM
    Curr Top Radiat Res Q; 1978 Jan; 12(1-4):389-407. PubMed ID: 565271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation quality-dependent bystander effects elicited by targeted radionuclides.
    Boyd M; Sorensen A; McCluskey AG; Mairs RJ
    J Pharm Pharmacol; 2008 Aug; 60(8):951-8. PubMed ID: 18644188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhomogeneity of the nucleus to 125IUdR cytotoxicity.
    Yasui LS; Hofer KG; Warters RL
    Radiat Res; 1985 Apr; 102(1):106-18. PubMed ID: 3920724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot clinical trial of 5-[125I]iodo-2'-deoxyuridine in the treatment of colorectal cancer metastatic to the liver.
    Macapinlac HA; Kemeny N; Daghighian F; Finn R; Zhang J; Humm J; Squire O; Larson SM
    J Nucl Med; 1996 Apr; 37(4 Suppl):25S-29S. PubMed ID: 8676200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model.
    Mairs RJ; Wideman CL; Angerson WJ; Whateley TL; Reza MS; Reeves JR; Robertson LM; Neshasteh-Riz A; Rampling R; Owens J; Allan D; Graham DI
    Br J Cancer; 2000 Jan; 82(1):74-80. PubMed ID: 10638969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiolabeled iododeoxyuridine: safety evaluation.
    Harrison KA; Dalrymple GV; Baranowska-Kortylewicz J; Holdeman KP; Schneiderman MH; Lieberman RP; Sharp JG; Cohen SM; Leichner PK; Augustine SC; Tempero MA; Taylor RJ; Chiou RK
    J Nucl Med; 1996 Apr; 37(4 Suppl):13S-16S. PubMed ID: 8676196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced IUdR radiosensitization by 241Am photons relative to 226Ra and 125I photons at 0.72 Gy/hr.
    Nath R; Bongiorni P; Rossi PI; Rockwell S
    Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1377-85. PubMed ID: 2370187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unlabelled iododeoxyuridine increases the cytotoxicity and incorporation of [1251]-iododeoxyuridine in two human glioblastoma cell lines.
    Xiao WH; Dupertuis YM; Mermillod B; Sun LQ; de Tribolet N; Buchegger F
    Nucl Med Commun; 2000 Oct; 21(10):947-53. PubMed ID: 11130336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and dosimetry of iodine-125-IUdR in the treatment of colorectal cancer metastatic to liver.
    Daghighian F; Humm JL; Macapinlac HA; Zhang J; Izzo J; Finn R; Kemeny N; Larson SM
    J Nucl Med; 1996 Apr; 37(4 Suppl):29S-32S. PubMed ID: 8676201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal photon energies for IUdR K-edge radiosensitization with filtered x-ray and radioisotope sources.
    Karnas SJ; Yu E; McGarry RC; Battista JJ
    Phys Med Biol; 1999 Oct; 44(10):2537-49. PubMed ID: 10533927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotoxicity of 125I in mammalian cells.
    Kassis AI; Fayad F; Kinsey BM; Sastry KS; Taube RA; Adelstein SJ
    Radiat Res; 1987 Aug; 111(2):305-18. PubMed ID: 3628718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iododeoxyuridine radiosensitization by low- and high-energy photons for brachytherapy dose rates.
    Nath R; Bongiorni P; Rockwell S
    Radiat Res; 1990 Dec; 124(3):249-58. PubMed ID: 2263725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model.
    Chi KH; Wang HE; Chen FD; Chao Y; Liu RS; Chou SL; Wang YS; Yen SH
    J Nucl Med; 2001 Feb; 42(2):345-51. PubMed ID: 11216535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.